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The progression of progenitors to oligoden-
drocytes requires proliferative arrest and the
activation of a transcriptional program of differ-
entiation. While regulation of cell cycle exit
has been extensively characterized, the molec-
ularmechanisms responsible for the initiation of
differentiation remain ill-defined. Here, we iden-
tify the transcription factor Yin Yang 1 (YY1) as
a critical regulator of oligodendrocyte progeni-
tor differentiation. Conditional ablation of yy1
in the oligodendrocyte lineage in vivo induces
a phenotype characterized by defective myeli-
nation, ataxia, and tremor. At the cellular level,
lack of yy1 arrests differentiation of oligoden-
drocyte progenitors after they exit from the
cell cycle. At the molecular level, YY1 acts as
a lineage-specific repressor of transcriptional
inhibitors of myelin gene expression (Tcf4 and
Id4), by recruiting histone deacetylase-1 to their
promoters during oligodendrocyte differentia-
tion. Thus, we identify YY1 as an essential com-
ponent of the transcriptional network regulating
the transition of oligodendrocyte progenitors
from cell cycle exit to differentiation.
INTRODUCTION
During development, oligodendrocytes derive from pre-
cursor cells residing throughout the neural axis (Pringle
and Richardson, 1993; Noll and Miller, 1993; Hall et al.,
1996; Miller, 2005; Richardson et al., 2006). Their matura-
tion into myelin-forming cells is a complex event that re-
quires exit from the cell cycle and the activation of a tran-
scriptional program leading to expression of myelin genes.
It was originally proposed that oligodendrocyte progenitor
differentiation is intrinsically regulated by a ‘‘timing’’
mechanism that links the number of cell divisions to
growth arrest and the initiation of differentiation (Templeand Raff, 1986). This mechanism was regulated by mito-
gens (Calver et al., 1998) and molecularly characterized
by the progressive accumulation of cell cycle inhibitors
(Durand et al., 1997). It was shown that genetic ablation
of cell cycle regulators impaired differentiation of progen-
itors into oligodendrocytes and promoted the persistence
of a proliferative state (Casaccia-Bonnefil et al., 1997; Du-
rand et al., 1998). However, overexpression studies with
viral vectors expressing cell cycle inhibitors did not induce
differentiation of progenitors, even though cells arrested
at the G1/S transition (Tikoo et al., 1998; Tang et al.,
1999; Ghiani and Gallo, 2001). Together these studies
suggested that cell cycle exit was necessary but not suf-
ficient to induce differentiation of progenitors into oligo-
dendrocytes. Because oligodendrocyte differentiation is
dependent on the bioavailability of transcriptional activa-
tors and the corresponding decrease of transcriptional
inhibitors (Wegner 2000; Stolt et al., 2002; Gokhan et al.,
2005; Ligon et al., 2006; Marin-Husstege et al., 2006; Liu
et al., 2006), in this study we investigate the mechanisms
at the interface between cell cycle exit and the initiation of
a transcriptional program of differentiation.
Previous studies from our group demonstrated that
global deacetylation of histone H3 is one of the first events
detected during this transition. Pharmacological inhibitors
of histone deacetylases (i.e., HDACs) prevented the ex-
pression of myelin genes in vitro (Marin-Husstege et al.,
2002) and developmental myelination in vivo (Shen et al.,
2005) and suggested that histone deacetylation was
necessary for the initiation of the transcriptional program
leading to myelin gene expression.
To identify possible molecular links between histone
deacetylation and transcriptional regulation of myelin
genes, we screened the promoters of genes regulated
by TSA, an inhibitor of HDAC activity during oligodendro-
cyte differentiation, for the presence of common binding
motifs, using Gene2Promoter software (Genomatix Soft-
ware GmbH, Munich). This analysis revealed the presence
of the consensus sequence NNCCATNN (Shrivastava and
Calame, 1994; Yant et al., 1995) for the transcription factor
Yin Yang 1 (YY1) in the promoter region of over 30% of the
genes downregulated by histone deacetylation during
oligodendrocyte differentiation. YY1 is a zinc-fingerNeuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc. 217
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YY1 in Developmental MyelinationFigure 1. Conditional Ablation of YY1 in
the Oligodendrocyte Lineage inMice Re-
sults in a Trembling Phenotype
(A) Conditional yy1 knockout mice (cko), ob-
tained by crossing yy1flox/flox with Cnp-cre
mice, displayed progressive tremor, ataxia,
and head wobbling starting from the second
postnatal week. Examples of abnormal postur-
ing and gait in the mutant mice (cko) at postna-
tal day 18 (p18) are shown in comparison with
control siblings (ctrl).
(B) Double immunostaining of cells in white
matter tracts of p18 mouse sections stained
for YY1 (red) and cell-specific markers (green):
CC1 for oligodendrocytes, GFAP for astro-
cytes, and NeuN for neurons. Note the specific
deletion of YY1 in oligodendrocytes. Scale bar,
20 mm.
(C) Quantitative real-time PCR of brain RNA
from wild-type (yy1+/+;cnp-cre+/), heterozy-
gotes (yy1flox/+;cnp-cre+/), and conditional
knockout (yy1flox/flox;cnp-cre+/) mice at p14.
The levels of the indicated transcripts are nor-
malized to GAPDH, and the mRNA control
levels are arbitrarily set as 100. The bar graph
indicates decreased myelin gene transcripts
in yy1 cko mice (black), but not in heterozygous
siblings (gray) compared to controls (white)
*p < 0.05, **p < 0.01. Error bars indicate
mean ± SD.
(D) Western blot analysis of protein lysates
from the cortex of p14 mice revealed de-
creased myelin basic protein (MBP) expression
in the mutants. b-actin serves as loading
control.
(E) Brain sagittal sections stained for PLP
(3wks) and for MBP (8wks) reveal fewer myelin-
ated fibers in the corpus callosum (cc), fornix
(f), and cerebellum of yy1 cko mice compared
to controls (ctrl). Scale bar, 100 mm.protein with the ability to bind DNA (Seto et al., 1991) and
function as a chromatin modifier (Thomas and Seto, 1999;
Liu and Shi, 2005). Genetic ablation of YY1 in mice re-
sulted in peri-implatation lethality and suggested a role
for YY1 in cell proliferation and differentiation (Donohoe
et al., 1999).
Here we present an in vivo analysis of yy1 condi-
tional knockout (cko) mice in the oligodendrocyte line-
age, and in combination with an integrated in vitro
approach, we define YY1 as a molecular regulator of the
transition from progenitors into myelinating oligodendro-
cytes.218 Neuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc.RESULTS
Conditional Ablation of YY1 in the Oligodendrocyte
Lineage Impairs Myelination
To assess the functional role of YY1 in oligodendrocyte
differentiation in vivo, we generated yy1 cko mice by
employing a Cre/lox strategy by crossing yy1flox/flox mice
(Affar et al., 2006) with a Cnp-cre line expressing the re-
combinase Cre from the oligodendrocyte lineage-specific
Cnp1 promoter (Lappe-Siefke et al., 2003). The resulting
homozygous yy1flox/flox;cnp-cre+/ mice (yy1 cko; Fig-
ure 1A) appeared to be normal at birth but developed
Neuron
YY1 in Developmental Myelinationshaking, ataxia, tremor, and head wobbling by 14 days of glycoprotein (mag), and ceramide-galactosyl transferase
Figure 2. Defective Myelination in the
Spinal Cord of yy1 Conditional Knockout
Mice
(A) Ultrastructural analysis of spinal cord sec-
tions shows lack of myelin (asterisks) and thin-
ner myelin sheaths (arrows) in p18 yy1 cko
mice compared to controls. Scale bar, 2 mm.
(B) Bar graph shows increased percentage of
unmyelinated axons relative to total number
of axons in the spinal cord of yy1 cko mice
(black) compared to controls (gray).
(C) Bar graph shows the relative distribution of
unmyelinated and myelinated axons in relation
to axonal diameter in the spinal cord of yy1 cko
mice (black) and controls (gray) at p18. *p <
0.05; **p < 0.01. Error bars indicate mean ± SD.
(D) Representative EM picture of a large yy1
cko spinal cord axon (diameter > 1.5 mm) that
lacks myelin (*) and is in contact with an astro-
cytic process (+). Scale bar, 200 nm.
(E) Representative EM pictures of myelinated
axons of equivalent diameter in control and
yy1 cko siblings. Scale bar, 100 nm.age (see Movie S1 in the Supplemental Data available with
this article online) that persisted throughout adulthood.
The cell-specific ablation of the yy1 gene in cells of the ol-
igodendrocyte lineage was confirmed by double immuno-
fluorescence using antibodies against YY1 and against
markers for different cell types: CC1 for oligodendrocytes,
GFAP for astrocytes, and NeuN for neurons (Figure 1B).
The lack of YY1 immunoreactivity in CC1+ oligodendro-
cytes, but not in other cell types, indicated that the gene
was efficiently excised in this lineage, although it was
still expressed in astrocytes and neurons. Heterozygote
yy1flox/+;cnp-cre+/mice did not show behavior abnormal-
ities and were undistinguishable from wild-type mice.
Because tremor and ataxia in yy1 cko mice were highly
reminiscent of the shaking phenotype described in mye-
lin-deficient mouse mutants (Nave, 1994; Griffiths, 1996),
we asked whether lack of YY1 inhibited myelin formation.
Quantitative RT-PCR revealed 80% lower levels of tran-
scripts for proteolipid protein (plp), myelin-associated(cgt) in the brains of p18 yy1 cko mice compared to
yy1+/+;cnp-cre+/ controls (Figure 1C). Decreased myelin
proteins were also detected by Western blot analysis
and immunohistochemistry in the CNS of homozygous
yy1 cko mice, but not in heterozygous mice (Figures 1D
and 1E). To determine whether this defective myelin
gene expression persisted through adulthood, we ana-
lyzed the brain (Figure 1E) and spinal cord (data not
shown) of adult cko mice and control siblings. Defective
myelination was still detected in 8-week-old yy1 mutant
mice, thereby indicating the lack of compensatory
mechanisms.
Defective myelination was confirmed by electron mi-
croscopy of the spinal cord, which revealed a 70% reduc-
tion of myelinated axons in yy1 cko mice compared to
controls (Figures 2A–2C). The few myelinated axons in
yy1 cko mice were characterized by thinner myelin
sheaths (Figures 2D and 2E) and higher g ratios (0.892 ±
0.045) compared to control siblings (0.774 ± 0.047,Neuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc. 219
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YY1 in Developmental MyelinationFigure 3. ImpairedOligodendrocyte Pro-
genitor Differentiation in the Spinal Cord
of yy1 Conditional Mutants
(A) Confocal image of lumbar spinal cord sec-
tions from controls (ctrl) and yy1 cko mice at
postnatal days 2, 11, and 18, stained with
antibodies specific for NG2 (green) to identify
progenitors, CC1 (red) to identify oligodendro-
cytes, and DAPI (blue) to counterstain nuclei.
Optical sections (Z, 1.0 mm; X, 12 mm) of confo-
cal epifluorescence images were sequentially
acquired, and LSM software was used to
merge images. Examples of NG2+/DAPI+ and
CC1+/DAPI+ cells selected for counting are
shown in the boxed areas (arrowheads), while
their relative position is shown at low magnifi-
cation (arrows). Scale bar, 50 mm, 10 mm in
inserts.
(B) Quantification of the data shown in (A). The
values indicate mean ± SD of cell counts ob-
tained in three to four mice of each genotype
per time point.
(C) Colocalization of progenitor markers
PDGFRa (red) and NG2 (green) in the spinal
cord of yy1 cko mice at p18. Scale bar, 20 mm.p < 0.0001). Therefore, we concluded that the ablation of
yy1 in oligodendrocyte progenitors significantly impaired
developmental myelination.
The phenotype detected in yy1 cko mice could be ex-
plained by hypothesizing a role for YY1 as transcriptional
activator of myelin gene expression. To test this hypothe-
sis, YY1 was overexpressed in the murine oligodendro-
cyte progenitor cell line Oli-neu (Jung et al., 1995), in the
absence or presence of myelin gene promoters driving
luciferase reporters. The increased levels of YY1 neither
affected the levels of endogenous myelin transcripts
nor activated luciferase reporter activity from the trans-
fected myelin promoters (Figure S1). Similar results were
obtained in rat-derived CG4 cells when the cells were
cultured in the presence of mitogens (data not shown).
However, when the cells were cultured in differentiation
conditions, YY1 overexpression increased the activity of
myelin gene promoters. Interestingly, YY1 increased not
only the activity of promoters containing YY1 binding sites
(i.e., plp; Berndt et al., 2001), but also of myelin gene
promoters (i.e., cgt and mbp) lacking consensus se-
quence for YY1 (Figure S1). Together these data sug-
gested a more global role for YY1 in regulating myelin
gene expression.220 Neuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc.Impaired Myelination in yy1 cko Mice Is Due to
Arrested Maturation of Oligodendrocyte Progenitors
A potential role for YY1 in the oligodendrocyte lineage,
suggested by the hypomyelinating phenotype of yy1 cko
mice, was a deficit in the maturation of oligodendrocyte
progenitors into myelin-forming cells. To test this hypoth-
esis, we conducted a temporal immunophenotypic analy-
sis of oligodendrocyte lineage cells in brain and spinal
cord sections of control and mutant mice at postnatal
days 2, 11, and 18 (Figure 3 and Figures S2 and S3). These
time points were chosen because they define the period of
oligodendrocyte differentiation and developmental myeli-
nation (Bjelke and Seiger, 1989; Hamano et al., 1998). We
used double immunofluorescence with antibodies spe-
cific for NG2 to identify progenitors and CC1 to identify
mature oligodendrocytes. Confocal microscopy was
used for image acquisition, and the relative proportion of
NG2+ and CC1+ cells was calculated as a percentage of
the total oligodendrocyte lineage population. At p2, a sim-
ilar proportion of NG2+ progenitors and CC1+ cells was
detected in the spinal cord of conditional mutants and
control siblings (Figure 3 and Table S1). By p18, however,
the oligodendrocyte lineage population of control mice
was composed of 60.6% ± 2.9% CC1+ cells while in yy1
Neuron
YY1 in Developmental Myelinationcko mice only 21.6% ± 1% of the cells were CC1+. Similar
differences were observed in the developing corpus cal-
losum (Figure S2). These results were confirmed by immu-
nohistochemistry using antibodies specific for the progen-
itor marker PDGFRa and for the lipid sulfatide recognized
by O4 (Figure S2). Therefore, we concluded that YY1 plays
a critical role in modulating the differentiation of progeni-
tors into CC1+ oligodendrocytes.
Because YY1 had been previously reported to nega-
tively regulate p53-induced apoptosis in lymphocytes
(Sui et al., 2004; Gronroos et al., 2004), we asked whether
the dramatic decrease of CC1+ cells detected in the yy1
cko mice could have been caused by increased apo-
ptosis. TUNEL assay (Gavrieli et al., 1992) revealed a
consistent but statistically insignificant increase of total
apoptotic cells in the corpus callosum of yy1 cko mice
compared to control siblings (Figure S2). Similar results
were obtained using immunohistochemistry and anti-
bodies specific for the activated form of the apoptosis ef-
fector caspase-3 (Gown and Willingham, 2002). At all of
the developmental time points analyzed (p2, p11, and
p18), we detected a statistically insignificant increase of
total apoptotic cells in yy1 cko compared to sibling con-
trols (Figure S4).
To further define the effect of YY1 deletion on oligoden-
drocyte differentiation, we performed in vitro ablation
experiments. Primary cultures of neonatal cortical oligo-
dendrocyte progenitors, from yy1flox/flox mice, were trans-
duced with adenoviral vectors (Gil-Perotin et al., 2006)
expressing the recombinase Cre from a CMV promoter
(adeno-CMV-Cre). Untransduced cultures of yy1flox/flox
progenitors were used as controls. The efficient excision
of yy1 was confirmed by immunocytochemistry (data not
shown). Differentiation was induced by mitogen with-
drawal, and the progression along the lineage was fol-
lowed using stage-specific markers, including immunore-
activity for the late progenitor marker O4 and for the
mature oligodendrocyte markers GalC, MBP, and PLP
(Figure 4A). The proportion of immunoreactive cells in
the YY1+ and YY1populations was quantified (Figure 4B).
After 3 days in differentiation conditions, more than 45%
of control cultures became O4+, and after 2 additional
days, a large proportion of the cells displayed the charac-
teristically branched morphology of mature oligodendro-
cytes and immunoreactivity for myelin proteins. In con-
trast, in Cre-transduced cells, at day 3 only 26% ± 3.1%
of cells were characterized by simple morphology and
O4+ immunoreactivity, and by day 5 all cells lacked the ex-
pression of myelin gene products.
Therefore, ablation of yy1 in oligodendrocyte progeni-
tors was incompatible with their differentiation into mye-
lin-forming cells.
Defective Differentiation in yy1 cko Mice
Is Independent on Impaired Cell Cycle Exit
Since the majority of the cells in yy1 cko mice retained the
progenitor markers NG2 and PDGFRa, it was conceivable
that the arrested maturation of these cells was due to theirabnormal persistence in the cell cycle. To test this hypoth-
esis, we assessed proliferation and cell cycle exit at sev-
eral time points of postnatal development in yy1 cko
mice and control siblings (Figure 5). The proliferation rate
was inferred by the relative proportion of cells in S phase,
calculated after a 1 hr in vivo pulse-labeling with the
Figure 4. In Vitro Ablation of yy1 in Oligodendrocyte Progen-
itors Prevents Their Differentiation into Oligodendrocytes
(A) Primary oligodendrocyte progenitors isolated from the cortex of
neonatal yy1flox/flox mice were transduced with adenoviral vectors ex-
pressing the recombinase Cre (CMV-Cre). Forty-eight hours later,
the cells were differentiated by mitogen withdrawal. Immunoreactivity
for O4 (green) was assessed 3 days later, while immunoreactivity for
MBP, GalC, or PLP (green) was assessed 5 days after transduction.
Note that the Cre+ yy1flox/flox cells (red) progressed to the O4+ stage,
but were unable to differentiate into myelin-expressing cells. Scale
bar, 50 mm.
(B) Quantification of three distinct experiments performed in duplicate.
*p < 0.05, ***p < 0.001. Error bars indicate mean ± SD.Neuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc. 221
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YY1 in Developmental Myelinationthymidine analog bromodeoxyuridine (BrdU). Immunohis-
tochemical analysis of sections of the neonatal spinal cord
of yy1 conditional knockout and control mice revealed
a similar progressive reduction of the proportion of
BrdU-labeled cells as the animals developed from p2 to
p18 (Figures 5A and 5B). Similar results were obtained in
primary cultures of yy1flox/flox oligodendrocyte progenitors
that were either not transduced or transduced with adeno-
CMV-Cre in order to ablate yy1 in vitro (Figure S5A). Con-
sistently, overexpression of YY1 in immortalized Oli-neu
progenitors did not change the proportion of BrdU-labeled
cells (Figure S5B) and did not affect the levels of cell cycle
regulators (Figure S5C). Together these data suggest that
Figure 5. Lack of YY1 Does Not Affect the Ability of Oligoden-
drocyte Progenitors to Exit from the Cell Cycle
(A) Confocal image of spinal cord sections of p2 yy1 cko and control
siblings (ctrl) in vivo labeled with BrdU for 1 hr. Immunohistochemistry
with YY1 (red), BrdU (green), and DAPI (blue) revealed a similar distri-
bution BrdU+ cells in mice of the two genotypes. Scale bar, 20 mm.
(B) Quantification of BrdU+ cells in white matter tracts of the spinal cord
at the indicated time points; error bars indicate average cell numbers ±
SD. *p < 0.05.
(C) Representative images of spinal cord sections of control and cko
mice stained with antibodies against Ki-67 (green) to identify cells in
any phase of the cell cycle except for G0 and BrdU (red) to identify cells
in S phase at the time of labeling.
(D) Cell cycle exit index was calculated by dividing the number of
BrdU+/Ki-67 cells by the total number of BrdU+ cells. Error bars indi-
cate mean ± SD.
Scale bar, 20 mm.222 Neuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc.YY1 does not affect cell division and that the NG2+ cells in
the yy1 cko mice were not proliferating.
To further rule out the possibility that oligodendrocyte
progenitors were unable to exit from the cell cycle in yy1
mutant mice, we performed double labeling with BrdU
and Ki-67 to calculate the cell cycle exit index (Chenn
and Walsh, 2002; Siegenthaler and Miller, 2005). Condi-
tional yy1 mice and control siblings received a single
BrdU injection and were sacrificed 1 hr later. The brains
were sectioned and immunostained with antibodies spe-
cific for BrdU, to label a cohort of cells in S phase, and
for Ki-67, to label proliferating cells throughout the phases
of the cell cycle, but not in G0. Double-immunoreactive
BrdU+/Ki-67+ cells measured the proportion of cycling
cells, while the remaining BrdU+/Ki-67 cells indicated
cells that had exited from the cell cycle. The cell cycle
exit index was calculated by dividing the number of
BrdU+/Ki-67 cells by the total population of BrdU+ cells.
Our results indicate that at p2, p11, and p18 the cell cycle
exit index was similar in cko and control mice (Figures 5C
and 5D). From these data we conclude that lack of YY1
does not affect the ability of oligodendrocyte progenitors
to exit from the cell cycle. In agreement with the similar ap-
optotic rate and cell cycle exit index, the total number of
cells measured in yy1 cko mice was similar to the number
measured in control siblings, at each of the developmental
points analyzed (Table S1).
Thus, the defective differentiation of oligodendrocyte
progenitor observed in the knockout mice could not be
explained in terms of increased apoptosis or persistent
proliferation.
YY1 Repress the Expression of Myelin Gene
Transcriptional Inhibitors
To understand how YY1 regulates oligodendrocyte pro-
genitor differentiation, we performed a gene expression
profile study of postnatal day 2 cko and control brains, us-
ing Affymetrix microarrays. Among the genes whose ex-
pression was affected by YY1 deletion, we focused our
analysis on those encoding for transcription factors and
validated their expression by RT-PCR (Figure 6A) and
quantitative RT-PCR (Figure 6B). We detected a 9-fold in-
crease of the transcription factor Tcf4, a 4-fold increase of
the differentiation inhibitor Id4, and a 2-fold increase of the
HMG-protein Sox11 (Figure 6B). No changes were de-
tected in the expression levels of nestin or REST, which
were previously shown to be regulated by YY1 in mouse
embryonic fibroblasts (Affar et al., 2006). A repressive
role for YY1 on the transcriptional regulation of the tran-
scription factors Tcf4 and Id4 was further supported by
overexpression studies in oligodendrocyte progenitors
(Figure 6C).
Id4 is a well-characterized inhibitor of oligodendrocyte
progenitor differentiation and myelin gene expression
(Kondo and Raff, 2000; Samanta and Kessler 2004;
Marin-Husstege et al., 2006). Tcf4 is a critical downstream
effector of Wnt signaling (Cho and Dressler, 1998; Tetsu
and McCormick, 1999), but its role in the oligodendrocyte
Neuron
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tional role of Tcf4 in the oligodendrocyte lineage, we coex-
pressed this factor with myelin gene promoters (i.e., mbp,
cgt) driving luciferase reporter genes. Cotransfection of
Tcf4 with luciferase reporter driven by the astrocyte-
specific promoter GFAP was used as control. Interestingly,
Tcf4 significantly decreased the activity of myelin gene
promoters compared to vector-transfected controls, but
did not affect the activity of the gfap promoter (Figure 6D).
Together, these data support a role for YY1 in oligoden-
drocyte progenitor differentiation that is dependent on the
downregulation of transcriptional inhibitors of myelin
genes.
Lineage-Specific Effect of YY1 in Oligodendrocyte
Progenitor Differentiation
The effect of yy1 ablation on oligodendrocyte progenitor
maturation raised the question of the specificity of this
transcription factor for the oligodendrocyte lineage. In
other words, it was important to define whether the func-
tion of YY1 in oligodendrocyte progenitor differentiation
was specific or whether YY1 was a transcription factor
that is universally required for the differentiation into any
Figure 6. YY1 Is a Repressor of Oligodendrocyte Differentia-
tion Inhibitors Id4 and Tcf4
(A) Validation of gene expression profiling studies in the cortex of yy1
cko mice and control littermates at p2, by semiquantitative (A) and
quantitative (B) RT-PCR.
(B) The bar graphs represent relateive RNA levels that were normalized
to the levels of GAPDH, and the values in the control mice were arbi-
trarily set as 1. Error bars indicate mean ± SD. *p < 0.05.
(C) The levels of Tcf4 and Id4 were downregulated in oligodendrocyte
progenitors transfected with pCX-yy1-EGFP (YY1) and not in cells
transfected with pCX-EGFP vector as control.
(D) Bar graphs represent the luciferase activity measured in extracts
from immortalized oligodendrocyte progenitors (Oli-neu cells) cotrans-
fected with Tcf4 and either myelin (mbp-luc, CGT-luc) or astrocyte-
specific (gfap-luc) promoters driving luciferase reporters. The lucifer-
ase activity in pCDNA3-transfected controls was arbitrarily set as
100; ** p < 0.01. The error bars indicate mean luciferase values ± SD.neural lineage. We therefore performed in vitro ablation
of yy1 in multipotential nestin+ precursors and then al-
lowed them to differentiate into distinct lineages (Figure 7).
Nestin+ precursors were generated from the subventricu-
lar zone of neonatal yy1flox/flox mice and grown in suspen-
sion as neurospheres (Figure 7A). After dissociation, the
cells were transduced with adeno-CMV-Cre, and yy1 ex-
cision was confirmed by immunocytochemistry (data not
shown). Untransduced cultures were used as controls.
Differentiation was induced by culturing the cells in a me-
dium permissive for differentiation along distinct lineages
(Belachew et al., 2003), and the cells were analyzed by im-
munocytochemistry, using markers specific for astrocytes
(i.e., GFAP), oligodendrocytes (i.e., GalC), and neurons
(i.e., TuJ1) (Figure 7A). The number of immunoreactive
cells in each lineage that was either YY1+ or YY1 was
counted and expressed as percentage of the total popula-
tion of cells (Figure 7B). Our results showed a decrease of
newly generated oligodendrocytes in cells lacking YY1 but
no statistically significant effect on the generation of neu-
rons or astrocytes (Figure 7B). To further evaluate the
effect of yy1 deletion on neuronal differentiation, we re-
peated the experiment and cultured the cells in conditions
promoting neuronal differentiation (i.e., in the presence
of retinoic acid; Wang et al., 2005). Also in this case, yy1
deletion did not significantly affect neurogenesis from
neonatal precursor cells (Figures 7C and 7D).
We therefore hypothesized that the lineage-specific role
of YY1 in the oligodendrocyte lineage included the tran-
scriptional regulation of the inhibitory transcription factors
Tcf4 and Id4. To test this hypothesis, YY1 was overex-
pressed in progenitors, and the cells were later allowed
to differentiate either into oligodendrocytes or into astro-
cytes. The RNA was isolated and the relative levels of
the transcripts were measured by quantitative real-time
PCR (Figure 8A). Consistent with a specific role of YY1
in the oligodendrocyte lineage, the levels of Tcf4 and Id4
were decreased only when cells differentiated into oligo-
dendrocytes, not when they differentiated into astrocytes
(Figure 8A). To understand the molecular basis of this
YY1-dependent lineage-specific repression of Tcf4 and
Id4, we performed coimmunoprecipitation with YY1 and
HDACs, the chromatin-modifying enzymes involved in
transcriptional repression and previously shown to be crit-
ical for oligodendrocyte differentiation (Marin-Husstege
et al., 2002; Shen et al., 2005). YY1 was immunoprecipi-
tated from protein extracts generated from undifferenti-
ated progenitors and from cells induced to differentiate
along the oligodendrocyte lineage. As control for lineage
specificity, we also included extracts from cells induced
to differentiate into astrocytes by BMP4 treatment. The
association was assayed by Western blot, using anti-
bodies specific for HDAC isoforms 1 and 2 (Figure 8B).
The association of YY1 with HDAC was weakly detected
in undifferentiated progenitors and astrocytes and was
enhanced in differentiating oligodendrocytes (Figure 8B).
Next, we examined the functional status of YY1 in relation
to the differentiative state of progenitors, using YY1Neuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc. 223
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YY1 in Developmental MyelinationFigure 7. In Vitro Ablation of yy1 in Nestin+ Precursor Cells Impairs Oligodendrocyte Differentiation in a Cell-Type-SpecificManner
(A) Subventricular zone (SVZ) cells were isolated from neonatal yy1flox/flox mice and cultured as nestin+ (green) neurospheres. Dissociated neuro-
spheres without (ctrl) or with adenovirus-CMV-Cre transduction (cre) were allowed to differentiate into oligodendrocytes, astrocytes, and neurons.
Seven days later, the cultures were stained for Cre (red) and the lineage-specific markers (green): Gal C (oligodendrocytes), GFAP (astrocytes),
and Tuj1 (neurons). Scale bar, 50 mm.
(B) Bar graphs indicate the percentage of immunoreactive cells relative to total cell number. *p < 0.05. Error bars indicate mean ± SD.
(C) The experiment was repeated in medium supplemented with retinoic acid (RA) to promote neuronal differentiation.
(D) Bar graphs show that even in this culture condition no significant difference was detected between control and yy1 cells. Error bars indicate
mean ± SD.TransLucent Reporter Vector (Panomics, CA). This vector
contains a luciferase reporter under the control of an en-
hancer element containing multiple YY1 binding sites, up-
stream of the minimal Herpes Simplex thymidine kinase
promoter (Dai et al., 2005). After transfection of this re-
porter vector in undifferentiated progenitors, cells were
exposed to mitogenic, astrogliogenic, or oligodendroglio-
genic stimuli, and luciferase activity was measured. In dif-
ferentiating oligodendrocytes, the luciferase activity was
3-fold higher than in astrocytes (Figure 8C). Therefore,
the functional ability of YY1 to bind DNA and form protein
complexes with HDAC was greater when progenitors dif-
ferentiated into oligodendrocytes rather than into astro-
cytes.
We then asked whether HDAC1 was recruited to YY1
binding sites (NNCCATNN; Shrivastava and Calame,
1994; Yant et al., 1995) in the promoter region of Tcf4
and Id4 (Figures 8D and 8E). Chromatin immunoprecipita-
tion (ChIP) was performed using antibodies against YY1 or
HDAC1, and the DNA was amplified using primers flanking
the promoter regions containing YY1 binding sites. Immu-
noprecipitation without antibodies and amplification with
primers in regions lacking YY1 consensus sequences
were used as negative controls. We detected increased
YY1 and HDAC1 recruitment to the same regions of the
Tcf4 promoter containing YY1 binding sites in differentiat-224 Neuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc.ing cells compared to undifferentiated cells (Figure 8D).
This was not observed when progenitors differentiated
into astrocytes (Figure 8D). A similar mechanism was
detected for the YY1-dependent regulation of the Id4
promoter (Figure 8E). Also in this case the enhanced
recruitment of HDAC1 to the YY1 binding sites was ob-
served when progenitors differentiated into oligodendro-
cytes, but not when they differentiated into astrocytes
(Figure 8E).
From the combined in vitro and in vivo evidence, YY1
emerges as a lineage-specific modulator of the transcrip-




Is Regulated by Intrinsic and Extrinsic Mechanisms
Myelination of the CNS is dependent on the correct exe-
cution of a genetic program of oligodendrocyte differenti-
ation that culminates with the timely and coordinated ex-
pression of several myelin genes. It is well established
that differentiation of oligodendrocytes from progenitors
requires exit from the cell cycle and the initiation of a tran-
scriptional program leading to myelin gene expression
(Bogler et al., 1990; Casaccia-Bonnefil and Liu, 2003).
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YY1 in Developmental MyelinationFigure 8. The YY1-Dependent Repression of Tcf4 and Id4 Is Lineage Specific and Mediated by Recruitment of HDAC1 to Their
Promoters
(A) The bar graphs indicate the relative mRNA levels of Tcf4, Id4, and REST by quantitative RT-PCR in oligodendrocyte progenitors transfected with
pCX-EGFP (vector) or pCX-yy1-EGFP (YY1) and induced to differentiate into astrocytes (astro) or oligodendrocytes (oligo). The transcripts in vector-
transfected cells were arbitrarily set as 100; *p < 0.05. Error bars indicate mean ± SD.
(B) Coimmunoprecipitation of YY1 and HDAC-1 and -2. Western blot analysis of whole-cell lysates (lysates) and YY1 immunoprecipitated protein ex-
tracts (IP:YY1) derived from undifferentiated progenitors (prog) and cells differentiated into oligodendrocytes (diff prog) or astrocytes (astro).
(C) YY1 activity, measured by TransLucent vector reporter system. Note the increased activity of YY1 in cultures of progenitors differentiating into
oligodendrocytes (diff. prog.) compared to undifferentiated cells (prog.) or cells differentiating into astrocytes (astro). **p < 0.01.
(D) Chromatin immunoprecipitation (ChIP) of samples isolated from progenitors (prog), differentiating oligodendrocytes (diff), or astrocytes (astro) and
immunoprecipitated with antibodies against YY1 and HDAC1. The diagram shows the Tcf4 promoter with the relative position of the YY1 consensus
sequences (black boxes) and the regions of DNA (roman numerals) amplified by specific primer pairs (arrows). Input DNA was used as positive control,
while ChIP in the absence of antibodies or amplification of immunoprecipitated chromatin with primers for region IV were used as negative controls.
(E) ChIP of samples isolated in the same conditions described above. The diagram shows the Id4 promoter, with the position of the YY1 consensus
sequence (black box) and the regions of the promoter (roman numerals) amplified by specific primer pairs (arrows). YY1 was bound to the Id4
promoter in progenitors, but it recruited HDAC1 only when cells differentiated into oligodendrocytes. No binding was observed in progenitors differ-
entiating into astrocytes.
(F) Model of oligodendrocyte progenitor differentiation as two-step event. First, proliferating progenitors exit from the cell cycle and remain in an
undifferentiated state characterized by high levels of transcriptional inhibitors (Id4, Tcf4) and lack of myelin gene expression. As the progenitors begin
differentiating, repressive complexes containing YY1 and HDAC1 are recruited to the promoter of these inhibitors. The decreased levels of these
inhibitory molecules allow myelin gene expression to begin.However, the events occurring during this transition re-
main unidentified. This study identifies a function for the
transcription factor YY1 as a molecule regulating the early
stages of oligodendrocyte progenitor differentiation after
cell cycle exit (Figure 8F).
Original studies in clonal cultures of oligodendrocyte
progenitors purified from the optic nerve suggested the
existence of a mechanism linking the activation of a dif-
ferentiation program to exit from the cell cycle (Templeand Raff, 1986; Hart et al., 1989). This concept was
supported by the evidence that mitogens prevent oligo-
dendrocyte progenitor differentiation (Gard and Pfeiffer,
1993; Barres et al., 1994; Calver et al., 1998; Nakatsuji
and Miller 2001) and that the ability of oligodendrocyte pro-
genitors to timely differentiate is delayed in animals with
genetic deletion of cell cycle regulators (Casaccia-Bonnefil
et al., 1997, 1999; Durand et al., 1997, 1998). Together,
these studies led to a model of lineage progression asNeuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc. 225
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YY1 in Developmental Myelinationbinary state, such that a progenitor could either proliferate
while remaining undifferentiated or progress to postmitotic
differentiated oligodendrocyte. However, the induction
of cell cycle exit was not sufficient, per se, to induce oligo-
dendrocyte progenitor differentiation (Tikoo et al., 1998;
Tang et al., 1999). Therefore, ‘‘differentiation’’ was rede-
fined as the linear succession of sequential states, from
proliferative and undifferentiated cells to quiescent pro-
genitors to mature oligodendrocytes (Pfeiffer et al.,
1993), each defined by a complex balance of positive
(i.e., Sox10, Mash1) and negative (i.e., Id4, Hes5) regula-
tors (Gokhan et al., 2005; Liu et al., 2006).
Previous studies from our laboratory defined HDAC ac-
tivity as necessary during the transition between cell cycle
exit and the initiation of a developmental program of differ-
entiation (Marin-Husstege et al., 2002; Shen et al., 2005).
In this study, we identify YY1 as the molecule that recruits
HDAC to the promoter of transcriptional inhibitors of mye-
lin genes (i.e., Id4, Tcf4). This YY1-mediated repressive
event occurs only when progenitors differentiate into oli-
godendrocytes, not when they become astrocytes.
YY1 Deletion Impairs Oligodendrocyte Progenitor
Differentiation without Affecting Cell Cycle Exit
The most prominent feature of in vivo ablation of yy1 in the
oligodendrocyte lineage is the detection of a shaking
phenotype characterized by ultrastructural evidence of
defective developmental myelination, due to impaired dif-
ferentiation of oligodendrocyte progenitors. In the spinal
cord, small-caliber axons show complete lack of myelin,
and a small percentage of large-caliber axons are wrap-
ped by thin myelin sheaths. At the biochemical level, de-
fective myelination in the yy1 cko mice is associated
with lower levels of myelin proteins and transcripts com-
pared to sibling controls and inefficient differentiation of
progenitors into myelinating oligodendrocytes.
In the CNS of control mice, progenitors differentiate into
myelinating oligodendrocytes during the first 3 weeks of
postnatal development. Differentiation can be assessed
by detecting a progressive decline in the number of cells
expressing progenitor markers and the corresponding in-
crease in the proportion of differentiated cells. In yy1 mu-
tants, we detect a greater proportion of cells expressing
progenitor markers that is paralleled by a smaller propor-
tion of mature oligodendrocytes.
A potential explanation for defective oligodendrocyte
progenitor differentiation was the possibility that progeni-
tors were retained in a proliferative state due to lack of yy1.
However, the ability of progenitors to exit from the cell cy-
cle and the number of cells in S phase are not affected by
YY1 levels. In addition, the increased absolute number of
progenitors during the first postnatal days, a distinctive
feature of defective differentiation due to persistent prolif-
eration (Casaccia-Bonnefil et al., 1997), is not detected in
yy1 cko mice. Rather, the differences between yy1 cko
mice and control siblings are best detected at later devel-
opmental time points, coincident with the acquisition of
a differentiated phenotype.226 Neuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc.Based on this cumulative evidence, we conclude that
YY1 modulates oligodendrocyte progenitor differentiation
independently of cell division.
YY1-Dependent Pathways Modulating Myelination
We have previously discussed the importance of positive
and negative regulators of myelin gene expression in de-
fining the transcriptional network that defines the myeli-
nating phenotype. In this study, the experimental results
identify the role of YY1 in oligodendrocyte differentiation
as lineage-specific repressor of genes that inhibit myelin
gene expression, including the repressive HLH protein
Id4 and the HMG protein Tcf4. Higher levels of Id4 and
Tcf4 were detected in the brains of yy1 cko mice com-
pared to control siblings, and lower levels of Id4 and
Tcf4 were detected in YY1-overexpressing cells com-
pared to the vector-transfected controls. The role of Id4
as an inhibitor of oligodendrocyte progenitor differentia-
tion and myelin gene expression has been previously de-
scribed (Kondo and Raff, 2000; Samanta and Kessler,
2004; Marin-Husstege et al., 2006). The role of Tcf4 as in-
hibitor of oligodendrocyte differentiation is less well de-
fined. Tcf4 is a member of the TCF/Lef family of HMG
box transcription factors, and it is highly expressed in
the developing central nervous system (Cho and Dressler,
1998; Korinek et al., 1998). Tcf4 is functionally upregulated
by the Wnt signaling pathway (Korinek et al., 1998), which
has been shown to inhibit oligodendrocyte differentiation
(Shimizu et al., 2005) and to be downregulated by the
Shh pathway, which favors oligodendrogliogenesis (Ishi-
bashi and McMahon, 2002). Other studies indicated that
the levels of Tcf4 are upregulated by the inhibition of
HDAC activity (Saegusa et al., 2005; Yamaguchi et al.,
2005). Taken together with our observation that Tcf4 re-
presses the promoter activities of myelin genes mbp and
cgt, this identifies Tcf4 as an inhibitor of oligodendrocyte
differentiation. Therefore, YY1 acts as repressor of tran-
scriptional inhibitors of the bHLH (i.e., Id4) and HMG
(i.e., Tcf4) family and enhances progenitor differentiation
and myelin gene expression. This explains also why YY1
overexpression increased the luciferase activity of re-
porters driven not only by the plp promoter (which con-
tains YY1 consensus sequences) but also that of reporters
driven by mbp or cgt promoters (which lack YY1 consen-
sus sequences) when the cultures were exposed to differ-
entiation conditions.
An alternative possibility was recently suggested by the
report that YY1 can also regulate the promoter of beta-site
amyloid precursor protein-cleaving enzyme 1 (bace1) in
primary neurons and astrocytes (Nowak et al., 2006).
BACE1 has been shown to influence myelination through
cleavage of neuregulins (Willem et al., 2006; Hu et al.,
2006). Even though the levels of BACE were not downre-
gulated in the yy1 cko (data not shown), we cannot ex-
clude the possibility that neuronal or astrocytic regulation
of BACE1 levels by YY1 could influence myelination in nor-
mal development.
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myelin gene expression is indirect and is mediated by the
recruitment of the chromatin modifier enzyme HDAC to
YY1 binding sites in the promoter of transcriptional inhib-
itors of myelin gene expression.
The Effect of YY1 on Oligodendrocyte Progenitor
Differentiation Is Lineage Specific
This study supports a cell-type-specific role of YY1 in the
oligodendrocyte lineage. In differentiating myoblasts (Lee
and Lee, 1994; Latinkic et al., 2004) and keratinocytes
(Xu et al., 2004), YY1 prevents the expression of differenti-
ation genes and is downregulated during differentiation
(Walowitz et al., 1998). In contrast, in oligodendrocyte lin-
eage cells, YY1 facilitates differentiation of progenitors,
and its expression remains constant throughout develop-
ment. Importantly, in vitro ablation of YY1 in nestin+ pre-
cursor cells prevents the generation of oligodendrocytes
but not other lineages. Finally, the transcriptional targets
of YY1 are not equivalent in distinct cell types. In mouse
embryonic fibroblasts, for instance, YY1 has been re-
ported to modulate the expression levels of REST, a re-
pressor of neuronal fate (Affar et al., 2006; Ballas et al.,
2005), but this was not detected in our study. The experi-
mental evidence provided in this study supports the role
of YY1 as lineage-specific activator of HDAC enzymatic
activity during oligodendrocyte progenitor differentiation.
This interpretation is based on the association of YY1
with the chromatin modifier enzyme HDAC1 only when
progenitors differentiate into oligodendrocytes, not when
they differentiate into astrocytes. The lineage-specific for-
mation of YY1/HDAC1 protein complexes was also asso-
ciated with a 3-fold greater DNA-binding activity of YY1
in progenitors differentiating into oligodendrocytes com-
pared to astrocytes. Finally, these data are consistent
with the detection of YY1/HDAC1 repressive complexes
in the promoter regions of Tcf4 and Id4 only during differ-
entiation of progenitors into oligodendrocytes. Therefore,
although previous studies had already reported the consti-
tutive association of YY1 with HDAC1 in HeLa (Yao et al.,
2001) and in erythroleukemia cell lines, our study demon-
strates an inducible and lineage-specific association be-
tween YY1 and HDAC1 in oligodendrocyte progenitors.
These results improve our understanding of oligoden-
drocyte development by providing a mechanistic insight
into the critical transition between cell cycle exit and initi-
ation of a transcriptional program of differentiation.
EXPERIMENTAL PROCEDURES
Animals
All of the mice used in this study were handled according to protocols
approved by the Institutional IACUC committee. Conditional yy1 mu-
tants were generated by crossing yy1flox/flox mice (Affar et al., 2006)
with Cnp1-cre mice (Lappe-Siefke et al., 2003), as detailed in Supple-
mental Experimental Procedures.
Antibodies and Plasmids
See Supplemental Experimental Procedures.Immunohistochemistry, Immunocytochemistry,
and Image Processing
Cells and sections were stained overnight with primary antibodies as
previously described (Marin-Husstege et al., 2006). After incubation
with fluorophore-conjugated secondaries, immunoreactivity was ana-
lyzed, using the Zeiss LSM 510 Meta confocal laser scanning micro-
scope. Image acquisition and quantification can be found in Supple-
mental Experimental Procedures.
BrdU Incorporation, Caspase-3 Immunohistochemistry,
and TUNEL Assays
Mice received 10 mg/kg BrdU injection 1 hr before sacrifice. After per-
fusion and cryopreservation, brains were sectioned and stained as
previously described (Shen et al., 2005). To identify the apoptotic cells,
terminal deoxynucleotidyl transferase-mediated dUTP end labeling
(TUNEL) assay and immunohistochemistry using an antibody against
activated cleaved 17/19 kD caspase-3 were performed (Supplemental
Experimental Procedures).
Electron Microscopy
Yy1 conditional mutant mice and control siblings were deeply anesthe-
tized and transcardially perfused with 0.9% NaCl followed by 0.1 M
Millonig’s solution containing 4% formaldehyde and 5% glutaralde-
hyde (pH 7.3). The mice were postfixed for 2 weeks in the same fixative
solution at 4C. Following the postfixation, tissue samples from cervi-
cal spinal cord and corpus callosum at the level of the fornix were har-
vested and processed for standard transmission electron microscopic
analysis as previously described (Dupree et al., 1998; Marcus et al.,
2006). For quantification details, see Supplemental Experimental
Procedures.
Neurosphere Culture of SVZ-Derived Multipotential Progenitors
The lateral SVZ was dissected from yy1flox/flox neonatal mice and dis-
sociated with papain. Approximately 1–2 3 104 SVZ cells (one brain)
per well of a 24-well plate were plated to form neurospheres and grown
in the presence of EGF and bFGF. After 7 days, the neurospheres were
mechanically dissociated and differentiated for 7 additional days into
several lineages (Supplemental Experimental Procedures).
Oligodendrocyte Progenitor Culture
Oligodendrocyte progenitors were isolated from postnatal day 1
cortex of rat or yy1flox/flox mice and immunoselected using A2B5 anti-
bodies (for rat cells) and NG2 antibodies (for mouse cells) and second-
ary antibodies conjugated with magnetic beads (Supplemental Exper-
imental Procedures). Progenitors were cultured in the presence of
bFGF and PDGF while oligodendrocyte differentiation was induced
by culturing the cells in the absence of mitogens (ODM) and astrocytic
differentiation by culturing the cells in BMP4 (100ng/ml). Viral trans-
duction, plasmid transfection protocols, and luciferase assays can
be found in Supplemental Experimental Procedures.
Quantitative and Semiquantitative Reverse Transcriptase PCR
Mouse brains or cell pellets were homogenized in Trizol reagent, and
RNA was isolated following the manufacturer’s instruction. Quantita-
tive real-time PCR was performed using Stratagene SYBR Green
PCR master mix in Stratagene MX4000 multiplex quantitative PCR
system (Supplemental Experimental Procedures).
Western Blot and Immunoprecipitation
Proteins from the brain were extracted as described in Liu et al. (2006),
and immunoprecipitation was conducted using standard biochemical
procedures (Supplemental Experimental Procedures).
Chromatin Immunoprecipitation
Chromatin was isolated from 1 3 107 oligodendrocyte progenitors
(Jung et al., 1995) that were cultured either in growth medium or in
oligodendrocyte differentiating medium or were induced to astrocyticNeuron 55, 217–230, July 19, 2007 ª2007 Elsevier Inc. 227
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YY1 in Developmental Myelinationlineage by BMP4 treatment. After immunoprecipitation with 5 mg anti-
YY1 antibody (mouse monoclonal sc-7341X, Santa Cruz) or 5 mg of
anti-HDAC1 antibody (rabbit polyclonal, Affinity BioReagents, Inc),
chromatin was reverse crosslinked using the EZ ChIP kit (Upstate Bio-
technology). Proteins were digested with proteinase K, and the recov-
ered DNA was purified using the QIAGEN QIAquick PCR purification kit
and subjected to PCR amplification as previously described (Liu et al.,
2006). Details are in Supplemental Experimental Procedures.
Statistical Methods
Results are expressed as mean ± standard deviation (SD) and statisti-
cally analyzed using two-tailed Student’s t tests. p < 0.05 was consid-
ered to be statistically significant. *p < 0.05, **p < 0.01, ***p < 0.001.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/55/2/217/DC1/.
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